Elbasvir/grazoprevir is effective and tolerable for the treatment of HCV GT1-infected patients: A real world multicenter observatory study in Taiwan

Publication date: Available online 22 May 2020Source: Journal of Microbiology, Immunology and InfectionAuthor(s): Pin-Nan Cheng, Chi-Yi Chen, Ming-Lung Yu, Chun-Che Lin, Chun-Yen Lin, Cheng-Yuan Peng, Kuo-Chih Tseng, Ching-Chu Lo, I-Hao Tseng, Chun-Jen Liu
Source: Journal of Microbiology, Immunology and Infection - Category: Microbiology Source Type: research